Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial☆
Titel:
Trastuzumab emtansine (T-DM1) in patients with HER2-positive metastatic breast cancer and brain metastases: exploratory final analysis of cohort 1 from KAMILLA, a single-arm phase IIIb clinical trial☆
Auteur:
Montemurro, F. Delaloge, S. Barrios, C.H. Wuerstlein, R. Anton, A. Brain, E. Hatschek, T. Kelly, C.M. Peña-Murillo, C. Yilmaz, M. Donica, M. Ellis, P.